Acute COVID-19 infection is followed by prolonged symptoms in approximately one in ten
cases: known as Long COVID. The disease affects~ 65 million individuals worldwide. Many …

Accumulating evidence points toward a very high prevalence of prolonged neurological
symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no …

Infection with SARS-CoV-2, the causative agent of the Coronavirus disease 2019 (COVID-
19) pandemic, causes respiratory problems and multifaceted organ dysfunction. A crucial …

Objective: To compare the two phases of long COVID, namely ongoing symptomatic COVID-
19 (OSC; signs and symptoms from 4 to 12 weeks from initial infection) and post-COVID-19 …

Background Clinical investigations have argued for long-term neurological manifestations in
both hospitalised and non-hospitalised COVID-19 patients. It is unclear whether long-term …

Objective The purpose of this study was to investigate the levels of fatigue and burnout in
nursing staff during the pandemic. Methods The present study involved nursing staff from …

OBJECTIVE: The novel coronavirus disease-19 (COVID-19) pandemic had intense social
and economic effects. Patients infected with COVID-19 may present with a series of …

COVID-19 is associated with neuropsychiatric complications, the most frequent one being
anxiety. Multiple biological and psychosocial factors contribute to anxiety in COVID-19 …

Objective: Despite the development of several vaccines against severe acute respiratory
syndrome coronavirus-2, the need for an additional prophylactic agent is evident. In recent …

At the end of 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was
discovered in China, causing a new coronavirus disease, termed COVID-19 by the WHO on …